Dr Bezalel MBBS

Resident doctor - Government Medical College Kozhikode | Ambassador @Metaacademy_ofc | Cardiology research | Aspiring Physician Scientist

[Dr Bezalel MBBS @DrBezMD]

No cardiology conference is complete without meeting & capturing a moment with your inspiration in clinical research. Glad to reconnect with Dr. Deepak L. Bhatt @DLBHATTMD after ESC 25 and continue to be inspired by his impactful work.

#ACC26 #cardiox

[Dr Bezalel MBBS @DrBezMD]

What does the evidence really say about caffeine and heart health? The AHA has weighed in.

#cardiology #cardiox #cardiotwitter #research #aha #americanheart

[AHA Science @AHAScience]

Studies of caffeine, one of the most commonly consumed drugs in the world, are largely observational, meaning that confounding by other factors remains an important consideration in interpreting the majority of scientific results. Therefore, more randomized controlled trials investigating the effects of caffeine on cardiovascular health are needed.

This scientific statement reviews and synthesizes evidence on the effects of caffeine on cardiovascular diseases.

✍🏼 @YepunaHB @MarilynCornelis @LarssonSC @gregorymmarcus

View the paper and supplemental resources here: https://t.co/BaSvRmBK02

[Meta Analysis Academy @metaacademy_ofc]

New publication from our Neurology Team in Neurology (AAN)! Congrats Luana and all the authors!

In patients undergoing acute migraine treatment, placebo response represents a substantial and growing share of trial outcomes driven by route of administration, baseline severity, and publication year, independent of drug-specific effects.
https://t.co/AN6ENaVd5o

#Neurology #MedTwitter #Migraine

[Rodolfo Lopes @rodolfolopesmd]

Excited to share that I’m officially applying for Cardiology Fellowship! Looking forward to the upcoming interview season. I’m incredibly grateful to the support from everyone up until this point.

AAMC ID: 16007586
#CardiologyFellowship #CardioTwitter #Match2027 #MedTwitter

[Dr Bezalel MBBS @DrBezMD]

@rodolfolopesmd @IvanRafaelMD Good Luck

[Iván Rafael Figueroa Báez @IvanRafaelMD]

With a grateful heart, I am officially applying for Cardiology Fellowship. 🫀

This journey has been filled with sacrifice, uncertainty, growth, and the support of many people who believed in me along the way. I remain hopeful, humble, and deeply committed to becoming the cardiologist I have always dreamed of being.

AAMC ID: 13324466

#CardiologyFellowship #CardioTwitter #MedTwitter #Match2027 #IMG

[Dr Bezalel MBBS @DrBezMD]

@IvanRafaelMD @christiankfuku @DrMarthaGulati @DrMichaelShapir @khurramn1 @CarlosVergaraMD @Jcontreras75 @rblument1 @onco_cardiology @ACCinTouch @ASPCardio @HanCardiomd Good Luck👍🏻

[Dr Bezalel MBBS @DrBezMD]

143 years of JAMA.

For generations, researchers, clinicians, and educators have turned to its pages to advance medical knowledge and improve patient care.

An extraordinary legacy of science, innovation, and evidence-based medicine.

https://t.co/VtiJQ5yCdb

#JAMA #Research #Medicine @KBibbinsDomingo @JAMA_current @JAMANetworkOpen

[Dr Bezalel MBBS @DrBezMD]

@DrJMarine @AdrianaCMares @metaacademy_ofc @Gamarra_NN Thankyou Dr Marine

[Dr Bezalel MBBS @DrBezMD]

Excited to share another publication!

Our latest work has been published in the Journal of Arrhythmia.

Research has become one of the most rewarding parts of my journey, and I’m grateful to all my co-authors, mentors and @metaacademy_ofc who have supported me along the way.

🔗 https://t.co/4zAqhXDDwl

#Cardiology #Research #MedTwitter #AcademicMedicine
@metaacademy_ofc @Gamarra_NN @DrJMarine @AdrianaCMares
@aphrs_jhrs_joa @APHRSOfficial @JHRS_PR @WileyGlobal @WileyHealth

[Dr Bezalel MBBS @DrBezMD]

Another milestone to celebrate!

I’m delighted to share that one of my co-authored research articles has been published in Neurology @GreenJournal - The most widely read and highly cited peer-reviewed neurology journal.

A meta analysis of 126 RCTs comprising 24,614 participants.

Grateful to all my co-authors and mentors who made this possible.
Thankful to @metaacademy_ofc for providing the training that helped shape my research skills.

Onward and upward!

🔗 https://t.co/uebmuoSaUu

@erickatsuyama97 @metaacademy_ofc
@Wolters_Kluwer @VanioAntunes @AANmember @wkhealth

#Neurology #Research #MedicalResearch #AcademicMedicine #PubMed #Science

[Dr Bezalel MBBS @DrBezMD]

10 PubMed indexed publications.

A small number in the grand scheme of science, but a milestone I’m proud of.

Thankful to my mentors, collaborators, and co-authors who made this journey possible. Special thanks to @metaacademy_ofc Meta-Analysis Academy for teaching me the art and science of meta analysis and helping shape my research journey.

Onward to the next one.

#PubMed #Research #MetaAnalysis #MedTwitter #AcademicMedicine #cardiology #cardiox #cardiotwitter

[Dr Bezalel MBBS @DrBezMD]

Pleased to share that another one of my co-authored publications is now out in the Journal of Interventional Cardiac Electrophysiology.

Grateful to all my co-authors & mentors. Special thanks to @metaacademy_ofc for providing the training and foundation that helped me contribute meaningfully to this work.

Proud to be part of this collaborative effort. On to the next!

https://t.co/IZSBHB2RIa

#Cardiology #Electrophysiology #Research #MetaAnalysis #MedTwitter #AcademicMedicine @JICE_EP @SpringerNature

[Dr Bezalel MBBS @DrBezMD]

Congratulations @RCardoso_MD ! A well-deserved achievement. Your dedication to cardiovascular research, commitment to mentorship, & willingness to teach have inspired countless young researchers around the world, including me. Wishing you continued success in everything ahead!

[Rhanderson Cardoso @RCardoso_MD]

I have always dreamed of being an author of a guideline.
It's a very important milestone. Besides being a relevant factor for promotion here in the US academic environment, there's all the prestige that comes with it.

doi: 10.1016/j.jcct.2026.05.006
#Cardiology #Research

[AHA Science @AHAScience]

Building on the First Definition of Heart Failure, the Second Definition refines HF staging with sharper stage criteria, emphasizing early detection and individualized risk reduction and introduces the universal classification of HF causes, with explicit acknowledgment of geographic variation in HF risk and outcomes. https://t.co/YDuE4stb5s

This updated document provides a unified, internationally harmonized framework intended to standardize terminology. It addresses changes in disease manifestations, diagnostic strategies, and understanding of pathophysiology.

✍🏼 @MinnowWalsh @KarenSliwa @amibanerjee1 @BiykemB @akshaydesaimd @DukeHFDoc @MKIttlesonMD @lamcardio @WilfriedMullens @NutritionHF

[Dr Bezalel MBBS @DrBezMD]

One year ago, I stood at #ISTH2025 in Washington DC presenting my abstract & received a $2000 Travel Award.
Since then: more abstracts, more presentations, more papers.
The constant through all of it? @metaacademy_ofc — they taught me how to turn a question into evidence.

[Dr Bezalel MBBS @DrBezMD]

Excited to present my abstract at #ISTH2025 in Washington, DC 🇺🇸!
Honored to be a Travel Award recipient—thank you to the ISTH Scientific Committee! 🙏
Looking forward to sharing my research and connecting with others on June 21–25. 🧬
#metaanalysis #isth #WashingtonDC
@isth

[Dr Bezalel MBBS @DrBezMD]

Proud to share our new meta-analysis just published in the Korean Journal of Pain.

A special thank you to @metaacademy_ofc- I learned how to conduct meta-analyses through their training, & this paper simply wouldn't exist without it. Deeply grateful for the skills & mentorship.

[Dr Bezalel MBBS @DrBezMD]

@mdandamudi25 @metaacademy_ofc Congratulations Dr Mrunalini

[Dr Bezalel MBBS @DrBezMD]

Breakthrough in pancreatic cancer treatment:
The RAS(ON) inhibitor daraxonrasib significantly improved overall survival AND progression-free survival vs. chemotherapy in previously treated metastatic PDAC.
Phase 3 RASolute 302 results are here 👇 #ASCO26
nej.md/4nWaxvM

[NEJM @NEJM]

Presented at #ASCO26:

Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq

@ASCO

[Rhanderson Cardoso @RCardoso_MD]

3,000 citations.

I am incredibly grateful to all my mentors, across multiple institutions, who helped me in my research journey to achieve this milestone.
Research has always been an important part of my academic journey (+).

[JAMA @JAMA_current]

.@JAMACardio Editor in Chief Barbara Casadei, MD, DPhil, reflects on the legacy of Eugene Braunwald, MD (1929-2026), whose contributions fundamentally shaped modern #cardiology.

https://t.co/PpGy1xbvWs